...
首页> 外文期刊>Medical Physics >Quantitative single-particle digital autoradiography with alpha-particle emitters for targeted radionuclide therapy using the iQID camera
【24h】

Quantitative single-particle digital autoradiography with alpha-particle emitters for targeted radionuclide therapy using the iQID camera

机译:使用iQID相机的定量单粒子数字放射自显影术与α粒子发射器的靶向放射性核素治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: Alpha-emitting radionuclides exhibit a potential advantage for cancer treatments because they release large amounts of ionizing energy over a few cell diameters (50-80 mu m), causing localized, irreparable double-strand DNA breaks that lead to cell death. Radioimmunotherapy (RIT) approaches using monoclonal antibodies labeled with alpha emitters may thus inactivate targeted cells with minimal radiation damage to surrounding tissues. Tools are needed to visualize and quantify the radioactivity distribution and absorbed doses to targeted and nontargeted cells for accurate dosimetry of all treatment regimens utilizing a particles, including RIT and others (e.g., Ra-223), especially for organs and tumors with heterogeneous radionuclide distributions. The aim of this study was to evaluate and characterize a novel single-particle digital autoradiography imager, the ionizing-radiation quantum imaging detector (iQID) camera, for use in alpha-RIT experiments.
机译:目的:发射α的放射性核素在癌症治疗中显示出潜在的优势,因为它们在少数几个细胞直径(50-80微米)上释放大量的电离能,从而导致局部的,不可修复的双链DNA断裂,从而导致细胞死亡。因此,使用标记有α发射体的单克隆抗体进行的放射免疫疗法(RIT)方法可以使靶细胞失活,而对周围组织的辐射损伤最小。需要工具来可视化和量化针对靶细胞和非靶细胞的放射性分布和吸收剂量,以便利用包括RIT和其他物质(例如Ra-223)在内的颗粒,特别是对于放射性核素分布不均的器官和肿瘤,对所有治疗方案进行精确剂量测定。这项研究的目的是评估和表征新型的单粒子数字放射自显影成像仪,即电离辐射量子成像检测器(iQID)相机,用于alpha-RIT实验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号